MNBTD
NVCR icon

Moody National Bank Trust Division’s NovoCure NVCR Stock Holding History

Moody National Bank Trust Division’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-88
Closed -$4K – 769
2019
Q1 		$4K Sell
88
-45
-34% -$2.17K ﹤0.01% 1069
2018
Q4 		$4K Buy
+133
New +$4.86K ﹤0.01% 973

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Moody National Bank Trust Division's NVCR Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of NovoCure (NVCR) in Q2 2019, closing a stake of 88 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in NVCR in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 197 funds tracked by Wall St. Rank hold NVCR as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining NovoCure position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 88 NovoCure shares in Q2 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in NovoCure in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's NovoCure position peaked at $4K in Q1 2019.
  • 197 funds tracked by Wall St. Rank held NovoCure as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.